We had high hopes in January of this year when IMU presented there its HER-Vaxx. It was reported to be " The Star " and yet, no buying of shares or deals came out of it.
Therefore I don't expect anything for CHM and IMU to happen as a result, those who are interested in the companies and their platforms already know what bargains both are. But maybe it will be different this time with world markets slowly coming back to invest in Bio-tech stocks. The data achieved so far definitely deserve to be presented, but all depends on those listening investors to be able to compare the information to the other shown presentations. CHM 1101 ( GBM CAR-T ) alone, the best treatment in the world atm, is worth USD billions once approved. Any suitor would get it almost for free plus the other platforms at current sp level.
As always, expecting the worst but hoping for the best.
GLTA
CHM Price at posting:
2.8¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)